David Green
About David Green
David Green serves as the Vice President of Discovery Pharmacology at Arcus Biosciences, a position he has held since 2024. He has extensive experience in the pharmaceutical industry, having previously worked in various senior roles at companies such as Amgen, Vertex Pharmaceuticals, and Abbott Laboratories.
Current Role at Arcus Biosciences
David Green serves as the Vice President of Discovery Pharmacology at Arcus Biosciences. He has held this position since 2024, contributing to the company's focus on innovative cancer therapies. His role involves overseeing pharmacological research and development, ensuring that the discovery process aligns with the company's strategic goals. Arcus Biosciences is located in Hayward, California, where Green applies his extensive experience in drug discovery and development.
Previous Experience in Pharmaceutical Industry
David Green has a robust background in the pharmaceutical industry, having held various leadership roles. He worked at Vertex Pharmaceuticals as Senior Director from 2008 to 2017, where he led teams in drug development. Prior to that, he was the Associate Director at Abbott Laboratories from 2003 to 2005. His career also includes positions at Amgen, Cubist Pharmaceuticals, Bristol-Myers Squibb, SmithKline Beecham, and Monsanto, showcasing a diverse range of experiences in pharmacology and drug discovery.
Educational Background in Biology and Chemistry
David Green earned his Bachelor of Arts degree in Biology and Chemistry from Earlham College, where he studied from 1977 to 1981. He furthered his education at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, obtaining a PhD in Biochemistry from 1982 to 1988. His educational foundation has equipped him with the necessary skills and knowledge to excel in the field of pharmacology.
Career Timeline and Progression
David Green's career spans several decades in the pharmaceutical sector. He began as a Postdoctoral Fellow at Monsanto from 1988 to 1989. He then progressed through various roles, including Senior Research Investigator at SmithKline Beecham and Bristol-Myers Squibb. His leadership roles continued at Cubist Pharmaceuticals, Amgen, Abbott Laboratories, Vertex Pharmaceuticals, and Alkermes, culminating in his current position at Arcus Biosciences.